1) lung adenocarcinoma A2
肺腺癌A2
1.
At different timepoints after curcumin treatment, Ang-1, Ang-2 and TSP mRNA levels were detected by RT-PCR and VEGF and MMP-9 protein expression levels were detected by Western blot using human lung adenocarcinoma A2 cells.
采用RT-PCR法及Western-blot法检测姜黄素作用人肺腺癌A2细胞不同时间后血管生成素(Ang-1、Ang-2)、血小板反应素(TSP)mRNA的表达水平和血管内皮生长因子(VEGF),基质金属蛋白酶(MMP-9)的蛋白表达水平。
2) lung adenocarcinoma A2 cell
肺腺癌细胞A2
3) pulmonary carcinoma cells (A2 cells)
肺癌A2细胞
4) pulmonary adenocarcinoma
肺腺癌
1.
Expression of cyclin D1 in female pulmonary adenocarcinoma;
女性肺腺癌中细胞周期素D1表达及意义
2.
Study of tumor-associated macrophage expression and angiogenesis in pulmonary adenocarcinoma;
肺腺癌肿瘤相关巨噬细胞的表达及与肿瘤血管生成的关系
3.
Analysis of the atypical CT finging of peripheral pulmonary adenocarcinoma;
不典型周围型肺腺癌CT误诊分析
5) lung adenocarcinoma
肺腺癌
1.
Expression of sFas in serum,Survivin and ERCC1 in tissue correlate with effect of paclitaxol plus cisplatin in lung adenocarcinoma cancer;
血清sFas,组织Survivin、ERCC1同肺腺癌TP方案疗效相关性
2.
Study of Mycobacterium Phlei on adjusting cell cycle kinetics in SPCA/Ⅰ human lung adenocarcinoma cancer cells;
草分枝杆菌调节SPCA/Ⅰ人肺腺癌细胞生长周期的研究
3.
Correlation of Tumor-Associated Macrophages Infiltration,VEGF-C Expression and Lymphangiogenesis in Lung Adenocarcinoma;
肺腺癌肿瘤相关巨噬细胞浸润和VEGF-C表达、淋巴管生成的关系
6) Lewis lung carcinoma
Lewis肺腺癌
1.
Assessment of the use of paclitaxel and cisplatin in advanced Lewis lung carcinoma in C57BL/6 mice;
C57BL/6小鼠晚期Lewis肺腺癌化疗疗效评价
补充资料：肺腺癌
肺腺癌
adenocarcinoma of lung
原发性肺癌的一种。发病率仅次于鳞癌。女性多见，多发生于肺周边小支气管的黏液腺，呈球形肿块，靠近胸膜。早期无明显症状，往往在X线检查时发现，生长较缓慢，但有的较早即发生血道转移。治疗可手术切除，对放射治疗敏感度差。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条